GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filaments

Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2414176121. doi: 10.1073/pnas.2414176121. Epub 2024 Dec 18.

Abstract

The pathological deposition of proteins is a hallmark of several devastating neurodegenerative diseases. These pathological deposits comprise aggregates of proteins that adopt distinct structures named strains. However, the molecular factors responsible for the formation of distinct aggregate strains are unknown. Here, we show that the serine/threonine kinase GSK3β catalyzes the aggregation of the protein tau into Alzheimer's disease (AD)-like filaments. We demonstrate that phosphorylation by GSK3β, but not by several other kinases, promotes the aggregation of full-length tau as well as enhances phase separation into gel-like condensate structures. Cryoelectron microscopy further reveals that the fibrils formed by GSK3β-phosphorylated tau adopt a fold comparable to that of paired helical filaments isolated from the brains of AD patients. Our results elucidate the intricate relationship between posttranslational modification and the formation of tau strains in neurodegenerative diseases.

Keywords: Alzheimer's disease; NMR; cryo-EM; phosphorylation; tau.

MeSH terms

  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Brain / metabolism
  • Brain / pathology
  • Cryoelectron Microscopy
  • Glycogen Synthase Kinase 3 beta* / metabolism
  • Humans
  • Phosphorylation
  • Protein Aggregates
  • Protein Aggregation, Pathological / metabolism
  • Protein Processing, Post-Translational
  • tau Proteins* / metabolism

Substances

  • tau Proteins
  • Glycogen Synthase Kinase 3 beta
  • MAPT protein, human
  • Protein Aggregates
  • GSK3B protein, human